Silver Book Fact

A study of Medicare beneficiaries with glaucoma showed that health care costs increased with degree of vision loss–ranging from $8,157 per year for no vision loss to $18,670 for blindness.

Bramely T, Peeples P, Walt J, Juhasz M, et al. Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries with Glaucoma. Arch Ophthalmol. 2008; 126(6): 846-56. http://archopht.ama-assn.org/cgi/reprint/126/6/849.pdf

Reference

Title
Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries with Glaucoma
Publication
Arch Ophthalmol
Publication Date
2008
Authors
Bramely T, Peeples P, Walt J, Juhasz M, et al.
Volume & Issue
Volume 126, Issue 6
Pages
846-56
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.  
  • More than 2 million Americans age 50 and older have age-related macular degeneration (AMD)—2,069,403.  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with glaucoma is $2.86 billion.  
  • Various studies found between 13% and 24% of age-related macular degeneration (AMD) patients had experienced visual hallucinations.  
  • The number of people in the U.S. with visual impairment or blindness is expected to double to more than 8 million by 2050.